HNL — Dr Hoenle AG Income Statement

0.000.00%

Last trade - 00:00

IndustrialsSpeculativeMicro CapNeutral

Annual income statement for Dr Hoenle AG, fiscal year end - September 30th, EUR millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	R2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	93.9	115	116	106	98.7
Cost of Revenue
Gross Profit	60.5	69.3	63.4	53.3	58.7
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	85.8	115	110	116	109
Operating Profit	8.1	0.349	5.84	-9.42	-10.3
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	7.85	-0.608	4.42	-11	-12.2
Provision for Income Taxes
Net Income After Taxes	5.61	-4.86	2.83	-11.3	-13
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	5.68	-4.82	-13.4	-11	-13.3
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	5.68	-4.82	-13.4	-11	-13.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.06	-0.816	0.258	-1.86	-1.3
Dividends per Share